Abstract:
Exemplary embodiments of solutions of plasma activated water and peroxyacetic acid are disclosed herein. In addition, exemplary embodiments of methods for making solutions are disclosed herein. Some methods include exposing water to a plasma gas to activate the water, adding acetic acid to the activated water; and mixing the acetic acid and activated water to form a solution. Additional exemplary methods include adding acetic acid to water to form a solution, mixing solution of acetic acid and water together; and exposing the solution to a plasma gas to activate the solution. Another exemplary embodiment includes exposing water to a plasma gas to activate the water; adding an acetyl group donor to the activated water; and mixing the acetyl group donor and activated water to form a solution.
Abstract:
Exemplary systems and methods associated with activating fluids using indirect plasma. In particular, liquid can be activated to high concentrations and at high volumes by thinning and mixing the liquid as it is exposed to the plasma, resulting more efficient activation. Further increases in activation can be reached by re-circulating fluid for additional exposure to the plasma. High flow rates can be achieved with integrated systems that utilize multiple activation systems with coordinated control.
Abstract:
Apparatuses (201, 301, 401, 501, 601, 701, 801, 901) for delivering bioactive substances or cosmetic substances using plasmaporation and microneedles are provided. The delivery of the substances includes topical, intracellular, intercellular, and transdermal delivery to the subject.
Abstract:
The nutrient rich water which is sprayed onto the roots of a plant being grown aeroponics or hydroponics is plasma-activated water generated by a non-thermal plasma.
Abstract:
Exemplary methods of and system for generating an antimicrobial wipe to clean and disinfect a surface contaminated with bacteria, viruses, spores, fungi, or combinations thereof. In some embodiments, the method includes applying non-thermal plasma to a moistened wipe to activate a liquid in the wipe. In some embodiments, the method includes applying non-thermal plasma to a liquid and then applying the activated liquid to a wipe. In one embodiment of a system for generating an antimicrobial wipe the system includes a housing having an opening; a supply of wipes disposed within the housing; a non -thermal plasma generator disposed within the housing; a power supply electrically coupled to the non-thermal plasma generator; and a feed system disposed within the housing, wherein the feed system moves one or more wipes from the supply of wipes past the plasma generator and out of the opening. As the feed system moves the wipes past the plasma generator, the plasma generator applies non-thermal plasma to the wipes.
Abstract:
Exemplary methods of improving the delivery of a substance encapsulated in a delivery vehicle to cells of interest in skin, tissue or tumor are disclosed herein.
Abstract:
Plasma treatment devices for reducing bacterial viability, enhancing stem growth, enhancing root growth or increasing germination times are disclosed herein. In addition, a treated sprout plant treated with a plasma activate medium or plasma with decreased bacterial viability relative to an untreated sprout plant. The treated sprout plant has at least a 1-log reduction in bacterial viability relative to the untreated sprout plant. Methods and apparatuses of producing the treated sprout plant are also provided.
Abstract:
Exemplary systems and methods of delivering DNA vaccines are disclosed herein. An exemplary methodology of delivering DNA vaccines includes providing a plasma generator for applying plasma to a treatment area for a sufficient period of time to open one or more pores. Applying a topical DNA vaccine to the treatment area and waiting for a period of time to allow the DNA vaccine to travel through the one or more pores. The exemplary methodology further includes applying plasma to the treatment area at a setting sufficient to cause intracellular uptake of the DNA vaccine.
Abstract:
A subject's skin is exposed to non-thermal plasma, thereby enabling analytes in the interstitial fluid in the subject's body to migrate to the surface of the subject's skin. The concentration of analytes in the subject's blood can be determined based on the amount of these analytes.
Abstract:
Exemplary embodiments of systems for generating large volumes of plasma activated liquids are disclosed herein. An exemplary system for creating a large volume of plasma- activated liquid includes a gas pump that moves a gas and liquid entrained in the gas, one or more plasma generators for generating plasma to activate at least one of the gas and the liquid entrained in the gas, a supply of liquid to be activated, a liquid aerator for creating an aerated liquid to be entrained in the gas, an activation chamber for activating the aerated liquid by contacting at least one of the aerated liquid or aerated liquid entrained in gas with plasma or plasma activated gas to form an activated liquid gas mixture. The exemplary system also includes a liquid gas separator positioned downstream of the activation chamber. The liquid gas separator separates at least a portion of the activated liquid gas mixture into an activated liquid and the gas. The activated liquid flows out of a first portion of the liquid gas separator and the gas flows out of a second portion of the liquid gas separator.